| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000025847 |
| Receipt No. | R000029721 |
| Official scientific title of the study | Endobiliary Radiofrequency Ablation Using a New Catheter for Malignant Biliary Strictures: A Prospective Multicenter Study |
| Date of disclosure of the study information | 2017/01/25 |
| Last modified on | 2017/01/25 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Endobiliary Radiofrequency Ablation Using a New Catheter for Malignant Biliary Strictures: A Prospective Multicenter Study | |
| Title of the study (Brief title) | Endobiliary radiofrequency ablation for malignant biliary strictures | |
| Region |
|
|
| Condition | ||
| Condition | Malignant biliary strictures by bile duct cancer, gallbladder cancer, or pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the safety and efficacy of endobiliary radiofrequency ablation (RFA) by using a new catheter in patients with malignant biliary strictures. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The incidence of early adverse events within 30 days after endobiliary radiofrequency such as hemobilia, bile duct perforation, pancreatitis, bleeding, cholangitis, perforation, or cholecystitis.
|
| Key secondary outcomes | Late adverse events after 30 days after endobiliary radiofrequency, stent patency of biliary metallic stent after endobiliary radiofrequency ablation, and patient survival after endobiliary radiofrequncy ablation. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Endobiliary radiofrequency ablation by using a new catheter and biliary metallic stenting through ERCP | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) More than 19 in age
2) Extrahepatic malignant biliary stricture that was histophathologically or clinically confirmed 3)Unresectable or inoperable due to comorbidity or refusal of operation 4) More than 3 months of predictive survival |
|||
| Key exclusion criteria | 1) Contraindications for ERCP
2) Uncontrolled coagulopathy: PT-INR > 1.5 (normal 0.85 - 1.25) or platelet count < 60,000/mm3 (normal 150,000 - 450,000/mm3) 3) Previously operation of bile duct 4) Impossible to access to the ampulla of Vater or failed selective biliary cannulation 5) Pregnant or breastfeeding women 6) Refusal to the study |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Hyun Jong Choi |
| Organization | SoonChunHyang University School of Medicine |
| Division name | Digestive Disease Center and Research Institute, Department of Internal Medicine |
| Address | 170 Jomaru-ro, Wonmi-gu, Bucheon 14584 |
| TEL | +82-32-621-5211 |
| joseph@schmc.ac.kr | |
| Public contact | |
| Name of contact person | Hyun Jong Choi |
| Organization | SoonChunHyang University School of Medicine |
| Division name | Digestive Disease Center and Research Institute, Department of Internal Medicine |
| Address | 170 Jomaru-ro, Wonmi-gu, Bucheon 14584 |
| TEL | +82-32-621-5211 |
| Homepage URL | |
| joseph@schmc.ac.kr | |
| Sponsor | |
| Institute | Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Digestive Disease Center and Research Institute, Department of Internal Medicine, SoonChunHyang University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029721 |